Pre-operative control of arterial hypertension using ketoconazole in pediatric patients with adrenocortical tumors

J Pediatr Endocrinol Metab. 2000 Feb;13(2):201-4. doi: 10.1515/jpem.2000.13.2.201.

Abstract

Adrenocortical tumors are rare in childhood, appearing more frequently in some regions such as South and South-eastern regions of Brazil and India. Common clinical signs include virilization, Cushing's syndrome, feminization and hypertension, either isolated or in association. The aim of this report is to present our experience with the pre-operative use of ketoconazole in children with an adrenocortical tumor to control elevated blood pressure levels non-responsive to the usual treatment. Over the last 16 years, of 46 children diagnosed as having adrenocortical tumor, 17 developed hypertension (diastolic pressure greater than the 95th percentile for age and sex according to data from the Task Force on Blood Pressure Control in Children), associated with virilization and/or Cushing's syndrome. In three of these 17 patients, conventional antihypertensive therapy failed, and they were treated with ketoconazole (200-300 mg/day). This resulted in rapid control of the blood pressure. It is concluded that in selected patients, ketoconazole may be useful adjuvant therapy for the palliative control of the arterial hypertension secondary to adrenocortical tumors, without side effects.

Publication types

  • Case Reports

MeSH terms

  • Adrenal Cortex Neoplasms / physiopathology*
  • Child, Preschool
  • Humans
  • Hypertension / drug therapy*
  • Infant
  • Ketoconazole / therapeutic use*
  • Male
  • Preoperative Care

Substances

  • Ketoconazole